Theraclion SA

EPA:ALTHE.PA

0.397 (EUR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q32013 Q22012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q4
Revenue 0.8410.9810.8850.3470.5960.8850.5770.1671.8210.9631.0730.8662.0270.7971.4520.5231.5420.0560.3250.4950.030.0190.0460.01900000.2340.2340.2340.2340.0530.0530.0530.053
Cost of Revenue 2.4533.6044.1433.7063.2892.7992.3772.1743.4613.341.9372.532.7452.4822.6991.9793.0681.7471.3951.3921.2180.5490.9770.5490.4460.4460.4460.4460.2770.2770.2770.2770.2490.2490.2490.249
Gross Profit -1.612-2.623-3.257-3.36-2.693-1.914-1.8-2.007-1.64-2.377-0.863-1.664-0.717-1.685-1.248-1.456-1.527-1.691-1.07-0.897-1.187-0.53-0.931-0.53-0.446-0.446-0.446-0.446-0.043-0.043-0.043-0.043-0.196-0.196-0.196-0.196
Gross Profit Ratio -1.917-2.674-3.679-9.696-4.518-2.164-3.12-12.018-0.901-2.468-0.804-1.922-0.354-2.114-0.859-2.784-0.99-30.235-3.292-1.814-38.96-27.694-20.233-27.694-594,609-594,608.333-594,609-594,608.333-0.182-0.182-0.182-0.182-3.676-3.676-3.676-3.676
Reseach & Development Expenses 004.303.820003.603.603.801.41.82.60000000000000000000
General & Administrative Expenses 000000000000000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000000000000000
SG&A 0.4570.5570.3790.0030.1170.0020.3790.10.3960.1940.4742.0840.8911.9972.162.1362.0581.4661.2731.2070.9090.0181.1450.0180.0120.0120.0120.0120.0120.0120.0120.0120.0090.0090.0090.009
Other Expenses 000-0.0880.015-0.037000.0710.01500000000000000000000000000
Operating Expenses 0.4570.5570.3890.0910.1020.0390.3790.10.3250.1792.0082.5292.4722.2652.4362.3782.0871.7771.5151.5081.0920.0181.1550.0180.0120.0120.0120.0120.0120.0120.0120.0120.0090.0090.0090.009
Operating Income -2.069-3.18-2.864-3.451-2.795-1.953-2.179-2.107-1.965-2.556-2.802-4.176-3.157-3.94-3.662-3.825-3.807-3.434-2.559-2.4-2.278-1.122-2.269-1.122-0.919-0.919-0.919-0.919-0.52-0.52-0.52-0.52-0.578-0.578-0.578-0.578
Operating Income Ratio -2.46-3.242-3.235-9.959-4.69-2.207-3.776-12.617-1.079-2.654-2.61-4.822-1.558-4.944-2.522-7.312-2.469-61.396-7.877-4.85-74.748-58.673-49.294-58.674-1,224,977-1,224,977-1,224,977-1,224,977-2.22-2.22-2.22-2.22-10.857-10.857-10.857-10.857
Total Other Income Expenses Net 2.0693.18-0.0480.3980.0770.028-0.138-0.203-2.1031.563-0.2-0.145-0.16-0.113-0.123-0.1380.102-0.1-0.077-0.124-0.09400.15200000-0-0-0-00000
Income Before Tax -1.744-2.98-2.913-3.053-2.718-1.925-2.317-2.31-4.068-0.993-3.002-4.321-3.318-4.054-3.785-3.962-3.705-3.534-2.636-2.524-2.372-1.122-2.116-1.122-0.919-0.919-0.919-0.919-0.52-0.52-0.52-0.52-0.578-0.578-0.578-0.578
Income Before Tax Ratio -2.074-3.038-3.29-8.811-4.56-2.176-4.016-13.832-2.234-1.031-2.797-4.99-1.637-5.086-2.607-7.575-2.403-63.186-8.114-5.102-77.827-58.673-45.989-58.674-1,224,977-1,224,977-1,224,977-1,224,977-2.22-2.22-2.22-2.22-10.857-10.857-10.857-10.857
Income Tax Expense -1.5530.5040.509-0.492-0.589-0.294-0.284-0.438-1.9490.680.4690.710.4950.6520.7420.470.4670.360.2840.2420.258-0.0940.119-0.094-0.151-0.151-0.151-0.151-0.101-0.101-0.101-0.101-0.099-0.099-0.099-0.099
Net Income -1.199-2.476-2.403-2.561-2.129-1.631-2.033-1.872-2.119-1.673-2.533-3.611-2.823-3.402-3.043-3.492-3.238-3.175-2.352-2.282-2.114-1.028-1.997-1.028-0.768-0.768-0.768-0.768-0.419-0.419-0.419-0.419-0.479-0.479-0.479-0.479
Net Income Ratio -1.426-2.524-2.714-7.391-3.572-1.844-3.523-11.21-1.164-1.737-2.36-4.17-1.392-4.268-2.096-6.677-2.101-56.755-7.238-4.613-69.354-53.738-43.397-53.739-1,024,252-1,024,252-1,024,252-1,024,252-1.787-1.787-1.787-1.787-8.992-8.992-8.992-8.992
EPS -0.041-0.0830-0.089-0.093-0.072-0.13-0.12-0.14-0.11-0.28-0.47-0.33-0.52-0.38-0.72-0.84-0.74-0.73-0.6-0.53-0.34-0.67-0.34-0.26-0.26-0.26-0.26-0.14-0.14-0.14-0.14-0.16-0.16-0.16-0.16
EPS Diluted -0.041-0.0830-0.089-0.093-0.072-0.13-0.12-0.14-0.11-0.28-0.47-0.33-0.52-0.38-0.72-0.84-0.74-0.73-0.6-0.53-0.34-0.67-0.34-0.26-0.26-0.26-0.26-0.14-0.14-0.14-0.14-0.16-0.16-0.16-0.16
EBITDA 0.066-3.076-2.785-3.368-4.405-1.886-2.065-1.996-2.432-2.048-2.628-4.009-2.978-3.758-3.518-3.652-3.659-3.207-2.406-2.249-2.048-1.047-2.197-1.047-0.809-0.809-0.809-0.809-0.433-0.433-0.433-0.433-0.501-0.501-0.501-0.501
EBITDA Ratio 0.079-3.136-3.145-9.72-7.391-2.131-3.579-11.951-1.335-2.126-2.449-4.629-1.469-4.715-2.423-6.981-2.374-57.327-7.406-4.546-67.213-54.737-47.742-54.738-1,078,745.667-1,078,745.667-1,078,745.667-1,078,745.667-1.847-1.847-1.847-1.847-9.411-9.411-9.411-9.411